ABT (Abbott Laboratories Inc.) שולי רווח גולמי

סמלים רשמיים של חברת Abbott Laboratories Inc. (ABT)

Abbott Laboratories revenue stability is based on excellent diversification across diagnostics, nutrition, and pharmaceuticals. The annual gross margin demonstrates the business's resilience to costs, while 52.30 represents the latest level. Growth is driven by FreeStyle Libre systems and elective surgeries, while the expansion of sales markets is supported by a global increase in chronic pathologies and demand for home tests.

ABT: רווחיות לפי רווח גולמי abbott.com 04.07.2022 - 19.11.2026

פילוחים אנליטיים ודוחות נתונים של חברת Abbott Corp. (ABT)

- מחיר ותחזית קונצנזוס למחירים:
ניתוח מסכם של החברה:Abbott Laboratories
מוצר ממותג של Abbott Laboratories Inc.

Gross margin is calculated as the difference between total revenue and direct production costs, expressed as a percentage of revenue. This indicator measures cost management efficiency and the business's pricing power in the market. For Abbott Laboratories (ABT), the integration of niche technologies and the expansion of distribution allow for cost optimization, maintaining high profitability. By analyzing the current gross margin level, an investor can assess the sustainability of the company's operating model.

מתחרים ישירים